Vanda Pharmaceuticals Inc’s filing revealed that its President and CEO Polymeropoulos Mihael Hristos acquired Company’s shares for reported $41500.0 on Aug 07 ’25. In the deal valued at $4.15 per share,10,000 shares were bought. As a result of this transaction, Polymeropoulos Mihael Hristos now holds 2,335,731 shares worth roughly $10.23 million.
Then, Mitchell Stephen Ray sold 7,000 shares, generating $32,130 in total proceeds. Upon selling the shares at $4.59, the Director now owns 97,082 shares.
Before that, Mitchell Stephen Ray bought 7,000 shares. Vanda Pharmaceuticals Inc shares valued at $32,159 were divested by the Director at a price of $4.59 per share.
B. Riley Securities initiated its Vanda Pharmaceuticals Inc [VNDA] rating to a Buy in a research note published on November 05, 2025; the price target was $11. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in late October with a ‘”a Buy”‘ rating. Cantor Fitzgerald began covering VNDA with “an Overweight” recommendation on July 11, 2024. Jefferies revised its rating on February 25, 2022. It rated VNDA as “a Hold” which previously was an “a Buy”.
Price Performance Review of VNDA
On Tuesday, Vanda Pharmaceuticals Inc [NASDAQ:VNDA] saw its stock fall -0.90% to $4.38. Over the last five days, the stock has gained 0.69%. Vanda Pharmaceuticals Inc shares have fallen nearly -12.75% since the year began. Nevertheless, the stocks have fallen -8.56% over the past one year. While a 52-week high of $5.70 was reached on 10/28/25, a 52-week low of $3.81 was recorded on 05/15/25.
Levels Of Support And Resistance For VNDA Stock
The 24-hour chart illustrates a support level at 4.34, which if violated will result in even more drops to 4.30. On the upside, there is a resistance level at 4.43. A further resistance level may holdings at 4.48.
How much short interest is there in Vanda Pharmaceuticals Inc?
A steep rise in short interest was recorded in Vanda Pharmaceuticals Inc stocks on 2025-10-31, growing by 0.32 million shares to a total of 3.98 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 3.67 million shares. There was a rise of 7.98%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on May 12, 2021 when BofA Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $22 price target.
